Earnings Preview: GeneDx Hldgs
Portfolio Pulse from Benzinga Insights
GeneDx Hldgs (NASDAQ:WGS) is scheduled to release its quarterly earnings report on February 20, 2024, with an expected EPS of $-0.75. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's beat resulting in a 30.34% drop. Shares are currently trading at $4.45, down 67.86% over the last year. Investors are looking for positive guidance for the next quarter.
February 19, 2024 | 8:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
GeneDx Hldgs is expected to report an EPS of $-0.75 for the upcoming quarter. The company's past earnings performance has shown significant volatility in stock price post-earnings announcement.
Given the historical performance where the stock price dropped significantly even after beating EPS estimates, the short-term impact is uncertain. The expected EPS of $-0.75 and the company's guidance for the next quarter will be key factors. However, the stock's recent downtrend and past volatility post-earnings suggest a cautious approach.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100